The lipid A component of bacterial lipopolysaccharides (endotoxins), when complexed to bovine serum albumin (BSA) or human serum albumin (HSA), was shown to be a potent pyrogen. Furthermore, rabbits could be protected against endotoxin fever by immunization with both lipid A BSA and lipid A HSA complexes. The results presented in this paper show that lipid A is responsible for the pyrogenic activity of endotoxins and their ability to induce pyrogenic immunity.
Endotoxins (lipopolysaccharides) of gramnegative bacteria, when injected into higher animals, cause a variety of pathophysiological effects (8) among which the febrile response in rabbits has been studied most intensively (16) . Repeated injections of endotoxins reduce the pyrogenic response, and there is strong evidence suggesting that this acquired resistance results from a classical immune response involving a 19S immunoglobulin specific to the toxic (pyrogenic) portion of the lipopolysaccharide molecules (9, 10) . Therefore, to describe acquired resistance to pyrogen, the term immunity (instead of tolerance) was proposed (9, 10) .
Recently, evidence was presented that the common lipid A component of lipopolysaccharides represents the toxic center of endotoxins (4, 5, 14) , as postulated earlier (19, 20) . Lipid A, when complexed to a solubilizing protein carrier, exhibited typical endotoxic effects such as Limulus lysate gelation (22) , lethal toxicity, anticomplementary activity, bone marrow necrosis, and pyrogenicity (5) .
In the present paper, the pyrogenic properties of lipid A complexed to bovine serum albumin (BSA) and human serum albumin (HSA) Lipid A and complexes of lipid A with BSA or HSA. Lipid A was prepared from the S. minnesota R595 glycolipid and the S. minnesota R345 lipopolysaccharide by acetic acid hydrolysis (0.1 N, 2.5 h, 100 C) as described previously (4) . No 
RESULTS
Determination of pyrogenicity (MPD-3) of lipid A-albumin complexes. The determination of the MPD-3 of a lipid A -BSA complex (lipid A derived from S. minnesota R595 glycolipid) is illustrated in Fig. 1 Immunity to lipid A -BSA was achieved (Fig. 3) . Two days later (day 10) the immune animals were tested with BSA (0.7 Ag/kg), and no significant fever response (A temperature = 0.8 F at 3 h) was observed (Fig. 3) . To assay for cross-immunity, the lipid A BSA immune rabbits were challenged 2 days later (day 12) with a 100-MPD-3 dose (0.5 ag/kg) of S. minnesota S lipopolysaccharide. Complete cross-immunity was observed (Fig. 3) .
To demonstrate reciprocal cross-immunity, rabbits were rendered immune to S. minnesota S lipopolysaccharide (Fig. 4, control demonstrated (Fig. 4) . In a control experiment, rabbits were immunized with BSA only (see Materials and Methods). When these animals were injected with BSA (0.7 gg/kg) 2 days later (day 10), no rise of the body temperature was observed. A normal biphasic fever curve was obtained however when the BSA-immunized rabbits were challenged 2 days later (day 12) with a 100-MPD-3 dose of lipid A *BSA (Fig. 5) .
Cross-immunity test between lipid A complexed to HSA and lipid A BSA and S. minnesota S lipopolysaccharide. Rabbits immunized with lipid A-HSA complex (lipid A from S. minnesota R345 lipopolysaccharide) showed good immunity when challenged with a 100-MPD-3 dose (1 ag/kg) of the homologous complex on day 8 (Fig. 6) . The lipid A * HSA immune rabbits were then cross-tested with 100-MPD-3 doses of lipid A BSA (0.1 4g/kg, day 10) and S. minnesota S lipopolysaccharide (0.5 ,ug/kg, day 12) . Complete cross-immunity to all toxins tested could be demonstrated (Fig. 6) . In addition, on day 14 the immune animals were cross-tested with a 100-MPD-3 dose of lipid A BSA Co-Wol BSA Immune VOL. 8, 1973 175
on October 15, 2017 by guest http://iai.asm.org/ Downloaded from complexed to RSA (0.5 ,g/kg). Good crossimmunity is evident (Fig. 6 ).
DISCUSSION
It is well known that endotoxins (lipopolysaccharides) of Salmonella wild-type (S) strains are potent pyrogens (16, 18, 19) . The demonstration that lipopolysaccharides (glycolipids) derived from R-mutant strains exhibit similar pyrogenicity (11, 12) indicated that the polysaccharide portion of lipopolysaccharides does not contribute specifically to pyrogenicity, but rather that the common lipid A component represents the pyrogenic center of endotoxins.
Recently, it could be shown that purified lipid A, when complexed to solubilizing carriers, exhibited endotoxic activity in a number of endotoxin tests, including fever induction in rabbits (5) . In the experiments presented in this study, lipid A complexed to BSA or HSA was used. Both lipid A-BSA and lipid A-HSA complexes exhibited pyrogenicity comparable to that of S-and R-form lipopolysaccharides. Thus, the pyrogenic principle of endotoxins is clearly embedded within their lipid A component.
Since the classical work of Beeson (1, 2), it has been well known that repeated injections of endotoxin into rabbits will render these animals resistant to pyrogenic (and lethal) activity of endotoxin, a phenomenon often referred to as "pyrogenic tolerance" (1, 7, 18) . It was also shown that pyrogenic cross-tolerance could be induced by serologically nonrelated lipopolysaccharides (10, 18) as well as by R-mutant endotoxins (11) . Furthermore, pyrogenic tolerance could be passively transferred by serum (9, 10) . From these observations it was concluded that acquired endotoxin resistance resulted from a classical immune mechanism involving 19S antibodies specific for lipid A but distinct from 0-or R-specific immunoglobulins. Consequently, it was proposed to substitute the term immunity for the term tolerance (9, 10) .
If pyrogenic immunity is a result of induction of lipid A-specific antibodies, it should be possible to protect animals against endotoxin fever by immunization with lipid A preparations. In earlier attempts, lipid A prepared from S-form lipopolysaccharides was shown to be a poor immunogen (18) . In the present study, Free lipid A, when solubilized with pyridine (18) or triethylamine (E. T. Rietschel, unpublished data), is pyrogenic but to a much lower degree (MPD-3 = 0.2 ug/kg). However, when complexed with BSA, RSA, and HSA, lipid A exhibits pyrogenic activity comparable to that of S-and R-form lipopolysaccharides. It appears therefore, that carriers such as albumins, by providing solubility and possibly exposing toxophore groups or a toxic conformation (13) within lipid A, allow the expression of optimal endotoxic activity of lipid A as previously suggested (4, 5) . The results presented and discussed in this paper suggest, in addition, that carriers such as BSA and HSA play a significant role for the immunogenic properties of lipid A. It is probable that 0-and R-poly(oligo)saccharides of endotoxins play a comparable role as carriers of lipid A.
Milner and Rudbach (Bacteriol. Proc. 96, 1968) and Griesman et al. (6, 7) using S-form lipopolysaccharides have demonstrated that pyrogenic tolerance is a biphasic phenomenon which can be separated into an early and a late phase. The early phase of tolerance exhibits no interendotoxin specificity and is thought to be due to cellular factors. The late phase of tolerance appears to be specific and to be mediated mainly by 0-specific immunoglobulins. However, antibodies with broader specificity were also shown to participate in the late phase tolerance (6, 7) . In the present paper, lipid A preparations, free of 0-polysaccharides, have been investigated. Preliminary experiments show that lipid A. albumin complexes readily induce the early phase of tolerance. However, this early tolerance is transient as demonstrated by the febrile response to daily injections of lipid A. albumin complexes. Therefore, the lipid A-induced pyrogenic tolerance (immunity) described in this paper appears to be distinct from the early phase of tolerance.
